首页> 美国卫生研究院文献>Journal of Lipid Research >The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation
【2h】

The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation

机译:凝血期间溶血磷脂酶A-1的磷脂酶A1活性将血小板活化与LPA产生联系起来

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Platelet activation initiates an upsurge in polyun­saturated (18:2 and 20:4) lysophosphatidic acid (LPA) production. The biochemical pathway(s) responsible for LPA production during blood clotting are not yet fully understood. Here we describe the purification of a phospholipase A1 (PLA1) from thrombin-activated human platelets using sequential chromatographic steps followed by fluorophosphonate (FP)-biotin affinity labeling and proteomics characterization that identified acyl-protein thioesterase 1 (APT1), also known as lysophospholipase A-I (LYPLA-I; accession code ) as a novel PLA1. Addition of this recombinant PLA1 significantly increased the production of sn-2-esterified polyunsaturated LPCs and the corresponding LPAs in plasma. We examined the regioisomeric preference of lysophospholipase D/autotaxin (ATX), which is the subsequent step in LPA production. To prevent acyl migration, ether-linked regioisomers of oleyl-sn-glycero-3-phosphocholine (lyso-PAF) were synthesized. ATX preferred the sn-1 to the sn-2 regioisomer of lyso-PAF. We propose the following LPA production pathway in blood: 1) Activated platelets release PLA1; 2) PLA1 generates a pool of sn-2 lysophospholipids; 3) These newly generated sn-2 lysophospholipids undergo acyl migration to yield sn-1 lysophospholipids, which are the preferred substrates of ATX; and 4) ATX cleaves the sn-1 lysophospholipids to generate sn-1 LPA species containing predominantly 18:2 and 20:4 fatty acids.
机译:血小板活化引发多不饱和(18:2和20:4)溶血磷脂酸(LPA)生产的增加。血液凝固过程中负责LPA产生的生化途径尚未完全了解。在这里,我们描述了使用顺序层析步骤从凝血酶激活的人血小板中纯化磷脂酶A1(PLA1),然后进行氟代磷酸盐(FP)-生物素亲和标记和蛋白质组学表征,该过程鉴定了酰基蛋白硫酯酶1(APT1),也称为溶血磷脂酶AI(LYPLA-I;登录号)作为新型PLA1。加入该重组PLA1显着增加了血浆中Sn-2-酯化的多不饱和LPC和相应LPA的产生。我们检查了溶血磷脂酶D /自分泌蛋白(ATX)的区域异构偏好,这是LPA生产的后续步骤。为了防止酰基迁移,合成了油基-sn-甘油-3-磷酸胆碱(溶血PAF)的醚连接区域异构体。 ATX优选溶血PAF的sn-1而不是sn-2区域异构体。我们提出以下血液中LPA的产生途径:1)活化的血小板释放PLA1。 2)PLA1生成sn-2溶血磷脂库; 3)这些新产生的sn-2溶血磷脂经过酰基迁移,生成sn-1溶血磷脂,它们是ATX的优选底物; 4)ATX裂解sn-1溶血磷脂,生成主要包含18:2和20:4脂肪酸的sn-1 LPA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号